𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene expression fluctuations in murine hematopoietic stem cells with cell cycle progression

✍ Scribed by Gerri J. Dooner; Gerald A. Colvin; Mark S. Dooner; Kevin W. Johnson; Peter J. Quesenberry


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
525 KB
Volume
214
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Evolving data suggest that marrow hematopoietic stem cells show reversible changes in homing, engraftment, and differentiation phenotype with cell cycle progression. Furthermore, marrow stem cells are a cycling population. Traditional concepts hold that the system is hierarchical, but the information on the lability of phenotype with cycle progression suggests a model in which stem cells are on a reversible continuum. Here we have investigated mRNA expression in murine lineage negative stem cell antigen‐1 positive stem cells of a variety of cell surface epitopes and transcription regulators associated with stem cell identity or regulation. At isolation these stem cells expressed almost all cell surface markers, and transcription factors studied, including receptors for G‐CSF, GM‐CSF, and IL‐7. When these stem cells were induced to transit cell cycle in vitro by exposure to interleukin‐3 (IL‐3), Il‐6, IL‐11, and steel factor some (CD34, CD45R c‐kit, Gata‐1, Gata‐2, Ikaros, and Fog) showed stable expression over time, despite previously documented alterations in phenotype, while others showed variation of expression between and within experiments. These latter included Sca‐1, Mac‐1, c‐fms, and c‐mpl. Tal‐1, endoglin, and CD4. These studies indicate that defined marrow stem cells express a wide variety of genes at isolation and with cytokine induced cell cycle transit show marked and reversible phenotype lability. Altogether, the phenotypic plasticity of gene expression for murine stem cells indicates a continuum model of stem cell regulation and extends the model to reversible expression with cell cycle transit of mRNA for cytokine receptors and stem cell markers. J. Cell. Physiol. 214: 786–795, 2008. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


In vivo expansion of transduced murine h
✍ Akihiro Kume; Masahide Koremoto; Ruifang Xu; Takashi Okada; Hiroaki Mizukami; Yu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract ## Background Hematopoietic stem‐cell‐directed gene transfer has achieved limited success in transducing clinically relevant levels of target cells. The expansion of gene‐modified cells is one way to circumvent the problem of inefficient transduction with current vectors. To this end,

Genes differentially expressed with mali
✍ Dong, Gang; Loukinova, Elena; Smith, Conrad W.; Chen, Zhong; Van Waes, Carter 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

Molecular changes occurring with tumor formation and metastasis need to be identified in order to define novel markers and targets for chemoprevention and therapy. Cell lines from a multistage model of murine squamous cell carcinoma were analyzed for differences in gene expression using mRNA differe

In vitro-generated stem cell leukaemia s
✍ Ralf Huss; Eva M. Weissinger; Claudia Lange; Petros Gatsios; Günther Eissner; Ha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

In an attempt to gain more insight into the events of leukaemic transformation, a cell line overexpressing MHC class II (DR) was generated by transfecting an early CD34-negative haematopoietic progenitor stem cell line with the appropriate constructs. The stable transfection with genes for DR antige

Targeted gene delivery to CD117-expressi
✍ Steven Froelich; Leslie Ziegler; Katie Stroup; Pin Wang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

## Abstract The development of a lentiviral system to deliver genes to specific cell types could improve the safety and the efficacy of gene delivery. Previously, we have developed an efficient method to target lentivectors to specific cells via an antibody–antigen interaction in vitro and in vivo.